Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide atazanavir or tenofovir-emtricitabine to HIV-infected
subjects who have completed atazanavir or tenofovir-emtricitabine therapy on a previous BMS
sponsored clinical trial and to collect long-term safety information on the treated
population.